Accentia, Johns Hopkins co-host meeting with prospective clinical trial investigators at AAN meeting Accentia Biopharmaceuticals, Inc. today announced that the business and leading doctors from Johns Hopkins University co-hosted a gathering with prospective clinical trial investigators at the recent American Academy of Neurology Annual Interacting with in New Orleans. Johns Hopkins University will serve seeing that the lead trial site for the scholarly study. An interview with Professor Lesley JonesAutoantibody status fails to predict death risk in systemic sclerosis with PAHDiabetic retinopathy therapy improvements: an interview with Richard Kirk, CEO of PolyphotonixA group of invited crucial opinion leaders and neurologists from leading Multiple Sclerosis Centers of Excellence attended the Cyrevia investigators meeting, hearing presentations from two Johns Hopkins doctors: Douglas E.‘Patients can’t distinguish which are great and which are harmful, and we’ve got to help them do that.’ To that final end, experts from around the national country have collaborated to form the Society for Integrative Oncology. This brand-new professional group is certainly a joint work of 3 major cancer centers with strong CAM programs – – Memorial Sloan-Kettering, MD Anderson Cancer Middle in Houston, and Boston’s Dana-Faber Tumor Institute – – as well as other cancer-related organizations, including the American Cancer Society. The new group retains its first conference in November.